Search
Recommended Sites
Related Links






   

Informative Articles

Asthma Inhalers - Introduction
The following article includes pertinent information that may cause you to reconsider what you thought you understood. The most important thing is to study with an open mind and be willing to revise your understanding if necessary. Inhalers...

b>Is Your Ability to Buy Dietary Supplements, Herbal Preparations, and Tonics in Jeopardy in the USA?
When the DSHEA (Dietary Supplement Health Education Act) was passed by the USA Congress in 1994 it was a boon to all of us consumers. Finally, we all could buy herbals that had long histories of safe and effective use throughout the world. Before...

Glucosamine Chondroitin & Arthritis
Many millions of people are affected by pain and suffering from Arthritis and research has shown that Glucosamine and Chondroitin sulphates combined have given these people new hope and relief from their painful ailments. Many medicines are...

Herbal Medicines - The Most Popular and Effective Natural Remedies
We've Come So Far - How Much Better Can Alternative Medicine Get? Herbal and natural medicine has gained so much more attention than it ever had in the past seven to ten years. So, why is that? There must be something to it other than a...

VIAGRA - Has the wonder drug been able to sustain the hype?
Viagra has exploded the market from the very first day when it came into existence some four years ago. The whole media and medicine world flocked to study the post launch effect and repercussions of the drug. Viagra dominated the talks and...

 
Acne: Asthma Drug Fails to Help Patients with Acne

The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.

Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos - far short of achieving statistical significance.

Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.

The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.

Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent "proof of concept" trial.

The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.

Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO). It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link.

About the author:

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution pr

Sign up for PayPal and start accepting credit card payments instantly.